Frequent nuclear accumulation of β-catenin in pituitary adenoma

Cancer

Volumn 91, Issue 1, 2001, Pages 42-48

  Semba, Shuho ^a   Han, Shuang Yin ^a   Ikeda, Hidetoshi ^a   Horii, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

catenin (CTNNB1); Nuclear accumulation; Pituitary adenoma; Somatic mutation

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; KI 67 ANTIGEN; PROTEIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELL ADHESION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOREACTIVITY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SOMATIC MUTATION; TUMOR GROWTH;

ADENOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; BETA CATENIN; CELL NUCLEUS; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUTATION, MISSENSE; PITUITARY NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035170199     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010101)91:1<42::AID-CNCR6>3.0.CO;2-7     Document Type: Article

References (37)

1. Diagnosis and management of hormone-secreting pituitary adenomas
2. Effect of an Rb mutation in the mouse
3. -/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance
4. The retinoblastoma gene in human pituitary tumors
5. Detection of heterozygous mutation in the retinoblastoma gene in a human pituitary adenoma using PCR-SSCP analysis and direct sequencing
6. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27-deficient mice
7. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
8. Molecular analysis of p21 and p27 genes in human pituitary adenomas
9. Mutations of the MEN1 tumor suppressor gene in pituitary tumors
10. p53 gene mutations in pituitary adenomas: Rare events
11. Molecular screening of pituitary adenomas for gene mutations and rearrangements
12. Tumor growth and biological markers in pituitary adenomas
13. Cadherin cell adhesion receptors as a morphogenetic regulator
14. -/- colon carcinoma
15. Association of the APC gene product with β-catenin
16. Down-regulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK-3β
17. Identification of c-Myc as a target of the APC pathway
18. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
19. Analysis and cloning of eukaryotic genomic DNA #9.14. Isolation of high-molecular weight DNA from mammalian cells
20. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein
21. Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary
22. Analysis of the p53 gene mutations in patients with multiple primary cancers
23. β-catenin expression in human cancers
24. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
25. E-cadherin and α-, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma
26. Beta- and gamma-catenin expression in thyroid carcinomas
27. Bridging of beta-catenin and glycogen synthase kinase-3β by axin and inhibition of beta-catenin-mediated transcription
28. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway
29. Mutations of the β-catenin gene in endometrial carcinomas
30. Dominant negative effect of the APC1309 mutation: S possible explanation for genotype-phenotype correlations in familial adenomatous polyposis
31. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
32. Co-regulation of pituitary tumor cell adhesion and prolactin gene expression by glucocorticoid
33. E-cadherin in human brain tumours: Loss of immunoreactivity in malignant meningiomas
34. Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas
35. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
36. Nuclear accumulation of β-catenin in human endocrine tumors: Association with Ki-67 (MIB-1) proliferative activity
37. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody